Vera Maria Avaldi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vera Maria Avaldi has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Jacopo Lenzi
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
5 shared publications - Maria Pia Fantini
University of Bologna, 40126 Bologna, Italy
5 shared publications - Paola Rucci
Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
4 shared publications Carlo Descovich
UOC Governo Clinico, Ricerca, Formazione e Sistema Qualità, Azienda USL di Bologna
3 shared publicationsStefano Urbinati
Department of Cardiology, Bellaria Hospital, Bologna, Italy
3 shared publicationsDario Molinazzi
Department of Management Control and Administrative Data, Bologna Local Healthcare Authority, Bologna, Italy
2 shared publications
Latest Publications
- 1 January 2022
- Published by Cultura e Salute Editore Perugia in Sistema Salute
- Vol. 66 (4) , 537-546
Ruolo dei PDTA nello sviluppo dei nuovi Modelli e Standard dell’Assistenza Territoriale: sfide e opportunità
Parole chiave: percorsi diagnostico terapeutico assistenziali, cronicità, Governo Clinico, DM77, assistenza primaria RIASSUNTO I percorsi diagnostico terapeutici assistenziali (PDTA) vengono definiti come piani di cura strutturati e multidisciplinari che delineano i passaggi essenziali per la cura di pazienti con specifici problemi di salute, favorendo l’applicazione locale dei risultati della ricerca scientifica, delle raccomandazioni delle linee guida e delle pratiche evidence-based. L’Azienda Usl di Bologna, a partire dal 2009, ha cominciato a sviluppare i PDTA come strumento di Governo Clinico per migliorare la qualità dell’assistenza e l’esperienza maturata negli anni ha permesso di consolidare pratiche e strumenti per l’attività di disegno, implementazione e monitoraggio dei percorsi. Tale esperienza aziendale relativa ai PDTA ha rivelato i loro punti di forza, ma anche le potenziali criticità e ha fatto emergere che spesso la loro progettazione e gestione può incontrare numerose barriere che riguardano sia aspetti inerenti i modelli organizzativi esistenti sia i comportamenti professionali. Il Decreto Ministeriale n 77/2022 pone la sfida della riforma della sanità territoriale, incentrandosi sulla personalizzazione delle cure, tipica della Sanità di Iniziativa. Alla luce dei cambiamenti organizzativi territoriali proposti ed in evoluzione negli ultimi anni, lo strumento del PDTA può essere considerato una risorsa per l’implementazione delle cure personalizzate ed integrate. I PDTA possono rappresentare un valore aggiunto per implementare le innovazioni previste nella sanità territoriale partendo dal metodo e dall’approccio di Governo Clinico con i quali i PDTA sono sviluppati, ma anche perché si configurano come strumenti per fornire linee di indirizzo sulle buone pratiche in un’organizzazione flessibile che permetta l’integrazione tra setting e professionisti. Inoltre, i PDTA possono rappresentare un’area di sperimentazione di strumenti di Telemedicina e rilanciare lo sviluppo e la declinazione delle attività di prevenzione e promozione della salute. Key Words: Clinical Pathways, chronic diseases, Clinical Governance; DM77, Primary Health Care SUMMARY Clinical pathways (CP) are defined as structured and multidisciplinary care plans that outline the essential steps for the treatment of patients with specific health problems, fostering the local application of the results of scientific literature, Guidelines and evidence-based practices. Since 2009 the Local Health Authority (LHA) of Bologna has begun to develop CPs as tools of clinical governance to improve the quality of care. The experience gained over the years has helped consolidate practices and tools to design, implement and monitor pathways. The LHA’s experience has highlighted the strengths of CPs as well as their potential limitations. It has also shown how their design and management can often meet several barriers that affect both existing organizational models and professional behaviors. The new Italian Primary Health Care Models and Standards, defined in the Ministerial Decree 77/2022, represents a new challenge to enhance patient-centered health care. In this context the CP model could add value in the implementation of the changes in the territorial Primary Health Care thanks to the CG method and approach. Moreover, CPs could introduce best practices, e-health tools and improve disease prevention and health promotion in a flexible organization system where the integration between professionals and setting is essential. Autore per corrispondenza: elisa.gabrielli4@studio.unibo.it
- 1 January 2022
- Published by Cultura e Salute Editore Perugia in Sistema Salute
- Vol. 66 (4) , 537-546
Ruolo dei PDTA nello sviluppo dei nuovi Modelli e Standard dell’Assistenza Territoriale: sfide e opportunità
Parole chiave: percorsi diagnostico terapeutico assistenziali, cronicità, Governo Clinico, DM77, assistenza primaria RIASSUNTO I percorsi diagnostico terapeutici assistenziali (PDTA) vengono definiti come piani di cura strutturati e multidisciplinari che delineano i passaggi essenziali per la cura di pazienti con specifici problemi di salute, favorendo l’applicazione locale dei risultati della ricerca scientifica, delle raccomandazioni delle linee guida e delle pratiche evidence-based. L’Azienda Usl di Bologna, a partire dal 2009, ha cominciato a sviluppare i PDTA come strumento di Governo Clinico per migliorare la qualità dell’assistenza e l’esperienza maturata negli anni ha permesso di consolidare pratiche e strumenti per l’attività di disegno, implementazione e monitoraggio dei percorsi. Tale esperienza aziendale relativa ai PDTA ha rivelato i loro punti di forza, ma anche le potenziali criticità e ha fatto emergere che spesso la loro progettazione e gestione può incontrare numerose barriere che riguardano sia aspetti inerenti i modelli organizzativi esistenti sia i comportamenti professionali. Il Decreto Ministeriale n 77/2022 pone la sfida della riforma della sanità territoriale, incentrandosi sulla personalizzazione delle cure, tipica della Sanità di Iniziativa. Alla luce dei cambiamenti organizzativi territoriali proposti ed in evoluzione negli ultimi anni, lo strumento del PDTA può essere considerato una risorsa per l’implementazione delle cure personalizzate ed integrate. I PDTA possono rappresentare un valore aggiunto per implementare le innovazioni previste nella sanità territoriale partendo dal metodo e dall’approccio di Governo Clinico con i quali i PDTA sono sviluppati, ma anche perché si configurano come strumenti per fornire linee di indirizzo sulle buone pratiche in un’organizzazione flessibile che permetta l’integrazione tra setting e professionisti. Inoltre, i PDTA possono rappresentare un’area di sperimentazione di strumenti di Telemedicina e rilanciare lo sviluppo e la declinazione delle attività di prevenzione e promozione della salute. Key Words: Clinical Pathways, chronic diseases, Clinical Governance; DM77, Primary Health Care SUMMARY Clinical pathways (CP) are defined as structured and multidisciplinary care plans that outline the essential steps for the treatment of patients with specific health problems, fostering the local application of the results of scientific literature, Guidelines and evidence-based practices. Since 2009 the Local Health Authority (LHA) of Bologna has begun to develop CPs as tools of clinical governance to improve the quality of care. The experience gained over the years has helped consolidate practices and tools to design, implement and monitor pathways. The LHA’s experience has highlighted the strengths of CPs as well as their potential limitations. It has also shown how their design and management can often meet several barriers that affect both existing organizational models and professional behaviors. The new Italian Primary Health Care Models and Standards, defined in the Ministerial Decree 77/2022, represents a new challenge to enhance patient-centered health care. In this context the CP model could add value in the implementation of the changes in the territorial Primary Health Care thanks to the CG method and approach. Moreover, CPs could introduce best practices, e-health tools and improve disease prevention and health promotion in a flexible organization system where the integration between professionals and setting is essential. Autore per corrispondenza: elisa.gabrielli4@studio.unibo.it
- Open Access
- 28 October 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (10) , e0223845
Are degree of urbanisation and travel times to healthcare services associated with the processes of care and outcomes of heart failure? A retrospective cohort study based on administrative data
A few studies have found that patients with heart failure (HF) living in less densely populated areas have reduced use of services and poorer outcomes. However, there is a lack of evidence regarding transport accessibility measured as the actual distance between the patient’s home and the healthcare facility. The aim of this study was to investigate if different urbanisation levels and travel times to healthcare services are associated with the processes of care and the outcomes of HF. This retrospective cohort study included patients residing in the Local Healthcare Authority of Bologna (2915 square kilometres) who were discharged from hospital with a diagnosis of HF between 1 January and 31 December 2017. Six-month study outcomes included both process (cardiology follow-up visits) and outcome measures (all-cause readmissions, emergency room visits, all-cause mortality). Of the 2022 study patients, 963 (47.6%) lived in urban areas, 639 (31.6%) in intermediate density areas, and 420 (20.8%) in rural communities. Most patients lived ≤30 minutes away from the nearest healthcare facility, either inpatient or outpatient. After controlling for a number of individual factors, no significant association between travel times and outcomes was present. However, rural patients as opposed to urban patients were more likely to see a cardiologist during follow-up (OR 1.42, 99% CI 1.03–1.96). These follow-up visits were associated with reduced mortality within 6 months of discharge (OR 0.53, 99% CI 0.32–0.87). We also found that multidisciplinary interventions for HF were more common in rural than in urban settings (18.8% vs. 4.0%). In conclusion, travel times had no impact on the quality of care for patients with HF. Differences between urban and rural patients were possibly mediated by more proximal factors, some of which are potential targets for intervention such as the availability and utilisation of follow-up cardiology services and multidisciplinary models of care.
- 28 October 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (10) , e0223845
Open AccessAre degree of urbanisation and travel times to healthcare services associated with the processes of care and outcomes of heart failure? A retrospective cohort study based on administrative data
A few studies have found that patients with heart failure (HF) living in less densely populated areas have reduced use of services and poorer outcomes. However, there is a lack of evidence regarding transport accessibility measured as the actual distance between the patient’s home and the healthcare facility. The aim of this study was to investigate if different urbanisation levels and travel times to healthcare services are associated with the processes of care and the outcomes of HF. This retrospective cohort study included patients residing in the Local Healthcare Authority of Bologna (2915 square kilometres) who were discharged from hospital with a diagnosis of HF between 1 January and 31 December 2017. Six-month study outcomes included both process (cardiology follow-up visits) and outcome measures (all-cause readmissions, emergency room visits, all-cause mortality). Of the 2022 study patients, 963 (47.6%) lived in urban areas, 639 (31.6%) in intermediate density areas, and 420 (20.8%) in rural communities. Most patients lived ≤30 minutes away from the nearest healthcare facility, either inpatient or outpatient. After controlling for a number of individual factors, no significant association between travel times and outcomes was present. However, rural patients as opposed to urban patients were more likely to see a cardiologist during follow-up (OR 1.42, 99% CI 1.03–1.96). These follow-up visits were associated with reduced mortality within 6 months of discharge (OR 0.53, 99% CI 0.32–0.87). We also found that multidisciplinary interventions for HF were more common in rural than in urban settings (18.8% vs. 4.0%). In conclusion, travel times had no impact on the quality of care for patients with HF. Differences between urban and rural patients were possibly mediated by more proximal factors, some of which are potential targets for intervention such as the availability and utilisation of follow-up cardiology services and multidisciplinary models of care.
- Open Access
- 19 July 2019
- Published by Springer Nature in PharmacoEconomics - Open
- Vol. 4 (1) , 181-190
Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree Analysis
Background and Objectives Many studies and systematic reviews have estimated the healthcare costs of diabetes using a cost-of-illness approach. However, in the studies based on this approach patients’ heterogeneity is rarely taken into account. The aim of this study was to stratify patients with type 2 diabetes into homogeneous cost groups based on demographic and clinical characteristics. Methods We conducted a retrospective cost-of-illness study by linking individual data on health services utilization retrieved from the administrative databases of Emilia-Romagna Region (Italy). Direct medical costs (either all-cause or diabetes-related) were calculated from the perspective of the regional health service, using tariffs for hospitalizations and outpatient services and the unit costs of prescriptions for drugs. The determinants of costs identified in a generalized linear regression model were used to characterize subgroups of patients with homogeneous costs in a classification and regression tree analysis. Results The study population consisted of a cohort of 101,334 patients with type 2 diabetes, followed up for 1 year, with a mean age of 70.9 years. Age, gender, complications, comorbidities and living area accounted significantly for cost variability. The classification tree identified ten patient subgroups with different costs, ranging from a median of €483 to €39,578. The two subgroups with highest costs comprised dialysis patients, and the largest subgroup (57.9%) comprised patients aged ≥ 65 years without renal, cardiovascular and cerebrovascular complications. Conclusions Classification of patients into homogeneous cost subgroups can be used to improve the management of, and budget allocation for, patients with type 2 diabetes.
- 19 July 2019
- Published by Springer Nature in PharmacoEconomics - Open
- Vol. 4 (1) , 181-190
Open AccessMedical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree Analysis
Background and Objectives Many studies and systematic reviews have estimated the healthcare costs of diabetes using a cost-of-illness approach. However, in the studies based on this approach patients’ heterogeneity is rarely taken into account. The aim of this study was to stratify patients with type 2 diabetes into homogeneous cost groups based on demographic and clinical characteristics. Methods We conducted a retrospective cost-of-illness study by linking individual data on health services utilization retrieved from the administrative databases of Emilia-Romagna Region (Italy). Direct medical costs (either all-cause or diabetes-related) were calculated from the perspective of the regional health service, using tariffs for hospitalizations and outpatient services and the unit costs of prescriptions for drugs. The determinants of costs identified in a generalized linear regression model were used to characterize subgroups of patients with homogeneous costs in a classification and regression tree analysis. Results The study population consisted of a cohort of 101,334 patients with type 2 diabetes, followed up for 1 year, with a mean age of 70.9 years. Age, gender, complications, comorbidities and living area accounted significantly for cost variability. The classification tree identified ten patient subgroups with different costs, ranging from a median of €483 to €39,578. The two subgroups with highest costs comprised dialysis patients, and the largest subgroup (57.9%) comprised patients aged ≥ 65 years without renal, cardiovascular and cerebrovascular complications. Conclusions Classification of patients into homogeneous cost subgroups can be used to improve the management of, and budget allocation for, patients with type 2 diabetes.
- 30 November 2017
- Published by Springer Nature
- Vol. 1067, 133-144
The Role of Cardiologists in the Management of Patients with Heart Failure
Heart failure is a complex clinical syndrome with a remarkable impact on health care systems in terms of patients’ morbidity and mortality, as well as direct and indirect costs. It is essential to redesign models of care for patients with heart failure that are tailored on personalized health care needs and carried out in the most appropriate setting. There is some debate about the role of cardiologists in the management of patients with heart failure. Indeed, results regarding the inclination of cardiologists’ patients to achieve better outcomes are controversial, given the heterogeneity of studies in terms of study design, population, setting and variables considered. The aim of this chapter is to describe and synthesize the current state of knowledge about the role of specialists in the management of patient with heart failure, and to assess whether there is a type of patients for which cardiologists demonstrate the greatest value or a setting of care where they add more benefit.
- 30 November 2017
- Published by Springer Nature
- Vol. 1067, 133-144
The Role of Cardiologists in the Management of Patients with Heart Failure
Heart failure is a complex clinical syndrome with a remarkable impact on health care systems in terms of patients’ morbidity and mortality, as well as direct and indirect costs. It is essential to redesign models of care for patients with heart failure that are tailored on personalized health care needs and carried out in the most appropriate setting. There is some debate about the role of cardiologists in the management of patients with heart failure. Indeed, results regarding the inclination of cardiologists’ patients to achieve better outcomes are controversial, given the heterogeneity of studies in terms of study design, population, setting and variables considered. The aim of this chapter is to describe and synthesize the current state of knowledge about the role of specialists in the management of patient with heart failure, and to assess whether there is a type of patients for which cardiologists demonstrate the greatest value or a setting of care where they add more benefit.
- Open Access
Effect of cardiologist care on 6-month outcomes in patients discharged with heart failure: results from an observational study based on administrative data
Objectives To evaluate the effect of cardiologist care on adherence to evidence-based secondary prevention medications, mortality and readmission within 6 months of discharge in patients with heart failure (HF). Design Retrospective observational study based on administrative data. Setting Local Healthcare Authority (LHA) of Bologna, one of the largest LHAs of Italy with ~870 000 inhabitants. Participants All patients residing in the LHA of Bologna discharged from hospital with a diagnosis of HF between 1 January 2015 and 31 December 2015. Primary and secondary outcome measures Multivariable regression analysis was used to assess the association of inpatient and outpatient cardiologist care with adherence to evidence-based medications, all-cause mortality and hospital readmission (including emergency room visits) within 6 months of discharge. Results The study population included 2650 patients (mean age 82.3 years). 340 (12.8%) patients were discharged from cardiology wards, while 635 (24.0%) were seen by a cardiologist during follow-up. Inpatient and outpatient cardiologist care was associated with an increased likelihood of adherence to ACE inhibitors/angiotensin receptor blockers (ACEIs/ARBs), β-blockers and aldosterone antagonists after discharge. The risk of mortality was significantly lower among patients adherent to ACEIs/ARBs and/or β-blockers (–53% and –28%, respectively); the risk of hospital readmission was significantly lower among patients adherent to ACEIs/ARBs (–28%). Conclusions Compared with non-specialist care, cardiologist care improves patient adherence to evidence-based medications and might thus favourably affect mortality and readmission following HF.
Open AccessEffect of cardiologist care on 6-month outcomes in patients discharged with heart failure: results from an observational study based on administrative data
Objectives To evaluate the effect of cardiologist care on adherence to evidence-based secondary prevention medications, mortality and readmission within 6 months of discharge in patients with heart failure (HF). Design Retrospective observational study based on administrative data. Setting Local Healthcare Authority (LHA) of Bologna, one of the largest LHAs of Italy with ~870 000 inhabitants. Participants All patients residing in the LHA of Bologna discharged from hospital with a diagnosis of HF between 1 January 2015 and 31 December 2015. Primary and secondary outcome measures Multivariable regression analysis was used to assess the association of inpatient and outpatient cardiologist care with adherence to evidence-based medications, all-cause mortality and hospital readmission (including emergency room visits) within 6 months of discharge. Results The study population included 2650 patients (mean age 82.3 years). 340 (12.8%) patients were discharged from cardiology wards, while 635 (24.0%) were seen by a cardiologist during follow-up. Inpatient and outpatient cardiologist care was associated with an increased likelihood of adherence to ACE inhibitors/angiotensin receptor blockers (ACEIs/ARBs), β-blockers and aldosterone antagonists after discharge. The risk of mortality was significantly lower among patients adherent to ACEIs/ARBs and/or β-blockers (–53% and –28%, respectively); the risk of hospital readmission was significantly lower among patients adherent to ACEIs/ARBs (–28%). Conclusions Compared with non-specialist care, cardiologist care improves patient adherence to evidence-based medications and might thus favourably affect mortality and readmission following HF.
- Open Access
Burden of multimorbidity in relation to age, gender and immigrant status: a cross-sectional study based on administrative data
Objectives Many studies have investigated multimorbidity, whose prevalence varies according to settings and data sources. However, few studies on this topic have been conducted in Italy, a country with universal healthcare and one of the most aged populations in the world. The aim of this study was to estimate the prevalence of multimorbidity in a Northern Italian region, to investigate its distribution by age, gender and citizenship and to analyse the correlations of diseases. Design Cross-sectional study based on administrative data. Setting Emilia-Romagna, an Italian region with ∼4.4 million inhabitants, of which almost one-fourth are aged ≥65 years. Participants All adults residing in Emilia-Romagna on 31 December 2012. Hospitalisations, drug prescriptions and contacts with community mental health services from 2003 to 2012 were traced to identify the presence of 17 physical and 9 mental health disorders. Primary and secondary outcome measures Descriptive analysis of differences in the prevalence of multimorbidity in relation to age, gender and citizenship. The correlations of diseases were analysed using exploratory factor analysis. Results The study population included 622 026 men and 751 011women, with a mean age of 66.4 years. Patients with multimorbidity were 33.5% in 75 years and >60% among patients aged ≥90 years; among patients aged ≥65 years, the proportion of multimorbidity was 39.9%. After standardisation by age and gender, multimorbidity was significantly more frequent among Italian citizens than among immigrants. Factor analysis identified 5 multimorbidity patterns: (1) psychiatric disorders, (2) cardiovascular, renal, pulmonary and cerebrovascular diseases, (3) neurological diseases, (4) liver diseases, AIDS/HIV and substance abuse and (5) tumours. Conclusions Multimorbidity was highly prevalent in Emilia-Romagna and strongly associated with age. This finding highlights the need for healthcare providers to adopt individualised care plans and ensure continuity of care.
Open AccessBurden of multimorbidity in relation to age, gender and immigrant status: a cross-sectional study based on administrative data
Objectives Many studies have investigated multimorbidity, whose prevalence varies according to settings and data sources. However, few studies on this topic have been conducted in Italy, a country with universal healthcare and one of the most aged populations in the world. The aim of this study was to estimate the prevalence of multimorbidity in a Northern Italian region, to investigate its distribution by age, gender and citizenship and to analyse the correlations of diseases. Design Cross-sectional study based on administrative data. Setting Emilia-Romagna, an Italian region with ∼4.4 million inhabitants, of which almost one-fourth are aged ≥65 years. Participants All adults residing in Emilia-Romagna on 31 December 2012. Hospitalisations, drug prescriptions and contacts with community mental health services from 2003 to 2012 were traced to identify the presence of 17 physical and 9 mental health disorders. Primary and secondary outcome measures Descriptive analysis of differences in the prevalence of multimorbidity in relation to age, gender and citizenship. The correlations of diseases were analysed using exploratory factor analysis. Results The study population included 622 026 men and 751 011women, with a mean age of 66.4 years. Patients with multimorbidity were 33.5% in 75 years and >60% among patients aged ≥90 years; among patients aged ≥65 years, the proportion of multimorbidity was 39.9%. After standardisation by age and gender, multimorbidity was significantly more frequent among Italian citizens than among immigrants. Factor analysis identified 5 multimorbidity patterns: (1) psychiatric disorders, (2) cardiovascular, renal, pulmonary and cerebrovascular diseases, (3) neurological diseases, (4) liver diseases, AIDS/HIV and substance abuse and (5) tumours. Conclusions Multimorbidity was highly prevalent in Emilia-Romagna and strongly associated with age. This finding highlights the need for healthcare providers to adopt individualised care plans and ensure continuity of care.
- Open Access
- 6 September 2016
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 473
Risk-adjustment models for heart failure patients’ 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record
Hospital discharge records (HDRs) are routinely used to assess outcomes of care and to compare hospital performance for heart failure. The advantages of using clinical data from medical charts to improve risk-adjustment models remain controversial. The aim of the present study was to evaluate the additional contribution of clinical variables to HDR-based 30-day mortality and readmission models in patients with heart failure. This retrospective observational study included all patients residing in the Local Healthcare Authority of Bologna (about 1 million inhabitants) who were discharged in 2012 from one of three hospitals in the area with a diagnosis of heart failure. For each study outcome, we compared the discrimination of the two risk-adjustment models (i.e., HDR-only model and HDR-clinical model) through the area under the ROC curve (AUC). A total of 1145 and 1025 patients were included in the mortality and readmission analyses, respectively. Adding clinical data significantly improved the discrimination of the mortality model (AUC = 0.84 vs. 0.73, p < 0.001), but not the discrimination of the readmission model (AUC = 0.65 vs. 0.63, p = 0.08). We identified clinical variables that significantly improved the discrimination of the HDR-only model for 30-day mortality following heart failure. By contrast, clinical variables made little contribution to the discrimination of the HDR-only model for 30-day readmission.
- 6 September 2016
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 473
Open AccessRisk-adjustment models for heart failure patients’ 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record
Hospital discharge records (HDRs) are routinely used to assess outcomes of care and to compare hospital performance for heart failure. The advantages of using clinical data from medical charts to improve risk-adjustment models remain controversial. The aim of the present study was to evaluate the additional contribution of clinical variables to HDR-based 30-day mortality and readmission models in patients with heart failure. This retrospective observational study included all patients residing in the Local Healthcare Authority of Bologna (about 1 million inhabitants) who were discharged in 2012 from one of three hospitals in the area with a diagnosis of heart failure. For each study outcome, we compared the discrimination of the two risk-adjustment models (i.e., HDR-only model and HDR-clinical model) through the area under the ROC curve (AUC). A total of 1145 and 1025 patients were included in the mortality and readmission analyses, respectively. Adding clinical data significantly improved the discrimination of the mortality model (AUC = 0.84 vs. 0.73, p < 0.001), but not the discrimination of the readmission model (AUC = 0.65 vs. 0.63, p = 0.08). We identified clinical variables that significantly improved the discrimination of the HDR-only model for 30-day mortality following heart failure. By contrast, clinical variables made little contribution to the discrimination of the HDR-only model for 30-day readmission.
- Open Access
- 26 May 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0127796
Hospital Readmissions of Patients with Heart Failure: The Impact of Hospital and Primary Care Organizational Factors in Northern Italy
Primary health care is essential for an appropriate management of heart failure (HF), a disease which is a major clinical and public health issue and a leading cause of hospitalization. The aim of this study was to evaluate the impact of different organizational factors on readmissions of patients with HF. The study population included elderly resident in the Local Health Authority of Bologna (Northern Italy) and discharged with a diagnosis of HF from January to December 2010. Unplanned hospital readmissions were measured in four timeframes: 30 (short-term), 90 (medium-term), 180 (mid-long-term), and 365 days (long-term). Using multivariable multilevel Poisson regression analyses, we investigated the association between readmissions and organizational factors (discharge from a cardiology department, general practitioners’ monodisciplinary organizational arrangement, and implementation of a specific HF care pathway). The 1873 study patients had a median age of 83 years (interquartile range 77–87) and 55.5% were females; 52.0% were readmitted to the hospital for any reason after a year, while 20.1% were readmitted for HF. The presence of a HF care pathway was the only factor significantly associated with a lower risk of readmission for HF in the short-, medium-, mid-long- and long-term period (short-term: IRR [incidence rate ratio]=0.57, 95%CI [confidence interval]=0.35–0.92; medium-term: IRR=0.70, 95%CI=0.51–0.96; mid-long-term: IRR=0.79, 95%CI=0.64–0.98; long-term: IRR=0.82, 95%CI=0.67–0.99), and with a lower risk of all-cause readmission in the short-term period (IRR=0.73, 95%CI=0.57–0.94). Our study shows that the HF care specific pathway implemented at the primary care level was associated with lower readmission rate for HF in each timeframe, and also with lower readmission rate for all causes in the short-term period. Our results suggest that the engagement of primary care professionals starting from the early post-discharge period may be relevant in the management of patients with HF.
- 26 May 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0127796
Open AccessHospital Readmissions of Patients with Heart Failure: The Impact of Hospital and Primary Care Organizational Factors in Northern Italy
Primary health care is essential for an appropriate management of heart failure (HF), a disease which is a major clinical and public health issue and a leading cause of hospitalization. The aim of this study was to evaluate the impact of different organizational factors on readmissions of patients with HF. The study population included elderly resident in the Local Health Authority of Bologna (Northern Italy) and discharged with a diagnosis of HF from January to December 2010. Unplanned hospital readmissions were measured in four timeframes: 30 (short-term), 90 (medium-term), 180 (mid-long-term), and 365 days (long-term). Using multivariable multilevel Poisson regression analyses, we investigated the association between readmissions and organizational factors (discharge from a cardiology department, general practitioners’ monodisciplinary organizational arrangement, and implementation of a specific HF care pathway). The 1873 study patients had a median age of 83 years (interquartile range 77–87) and 55.5% were females; 52.0% were readmitted to the hospital for any reason after a year, while 20.1% were readmitted for HF. The presence of a HF care pathway was the only factor significantly associated with a lower risk of readmission for HF in the short-, medium-, mid-long- and long-term period (short-term: IRR [incidence rate ratio]=0.57, 95%CI [confidence interval]=0.35–0.92; medium-term: IRR=0.70, 95%CI=0.51–0.96; mid-long-term: IRR=0.79, 95%CI=0.64–0.98; long-term: IRR=0.82, 95%CI=0.67–0.99), and with a lower risk of all-cause readmission in the short-term period (IRR=0.73, 95%CI=0.57–0.94). Our study shows that the HF care specific pathway implemented at the primary care level was associated with lower readmission rate for HF in each timeframe, and also with lower readmission rate for all causes in the short-term period. Our results suggest that the engagement of primary care professionals starting from the early post-discharge period may be relevant in the management of patients with HF.
- 11 February 2014
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 19 (2) , 191-197
Mental health services use and management of eating disorders in an Italian Department of Mental Health
To investigate the clinical characteristics of patients with eating disorders referred to Community Mental Health Centers (CMHCs) in the Department of Mental Health of Bologna, Italy, and to evaluate the number and type of interventions delivered.
- 11 February 2014
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 19 (2) , 191-197
Mental health services use and management of eating disorders in an Italian Department of Mental Health
To investigate the clinical characteristics of patients with eating disorders referred to Community Mental Health Centers (CMHCs) in the Department of Mental Health of Bologna, Italy, and to evaluate the number and type of interventions delivered.